USPTO serial 85325612
APTALIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOTT, MAUREEN DALL
- Law office
- PETITIONS OFFICE
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with APTALIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MONT-SAINT-HILAIRE, QUEBEC, CA
Quebec, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew O. Brady
Matthew O. Brady Aptalis Pharma Canada Inc., c/o Actavis, Inc.400 Interpace ParkwayMorris Corporate Center IIIParsippany, NJ 07054Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for the pharmaceutical sector, namely, chemical formulations that affect release properties for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | A full line of pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals; dietetic foods and substances, namely, nutritional supplements, nutritionally fortified beverages, nutritional drinks and drink mixes for use as a meal replacement, all adapted for medical and clinical use; a full line of medicinal preparations, both prescription and over-the-counter, for use in connection with humans and animals; pharmaceutical preparations in the form of a liquid, powder, tablet, capsule, granule and gel, for the treatment of gallstones and disorders of the liver, intestines, stomach, pancreas, lungs, esophagus, and gallbladder; pharmaceutical products, namely, antibiotics, anti-inflammatory preparations, antifungal preparations, antispasmodic preparations, anti-ulcerous preparations, tranquilizers, anti-histaminic preparations, and pancreatic enzymes for gastro-intestinal symptoms and diseases; pharmaceutical products for regulating weight; vitamins; spasmolytic preparations, namely, pharmaceutical preparations for use in relieving spasms; preparations in the form of liquid or powders intended for dialysis, namely, liquid-based and powder-based pharmaceutical preparations for use in treating the kidney during dialysis; pharmaceutical preparations for the diagnosis and treatment of tumors; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system | ACTIVE | — |
| 010 | Medical devices, namely, lasers, mucus clearance devices, hypodermis and acupuncture needles, syringes, medical apparatus for facilitating the inhalation of pharmaceutical preparations | ACTIVE | — |
| 016 | Printed matters in the field of medicine, namely, books, brochures, pamphlets and tabloids | ACTIVE | — |
| 035 | Providing an internet website featuring business information in the fields of medicine and pharmaceuticals; providing an intranet website featuring business information in the fields of medicine and pharmaceuticals | ACTIVE | — |
| 041 | Organization of educational services, conferences, symposiums and educational teaching programs, namely, organization of educational presentations, classes and workshops in the field of medicine and physical disorders, intended to encourage the exchange of information concerning the treatment of various physical disorders, and distributing course materials provided in connection therewith | ACTIVE | — |
| 042 | Research and development of technology in the field of pharmaceuticals for use in the pharmaceutical industry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by APTALIS PHARMA CANADA INC.
- Other trademarks owned by AXCAN PHARMA INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named APTALIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 7, 2015 | PCDE | PETITION TO DIRECTOR DENIED | — |
| Jul 6, 2015 | APET | ASSIGNED TO PETITION STAFF | — |
| Jun 2, 2015 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| May 29, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 29, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 29, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 5, 2014 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 5, 2014 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 5, 2014 | GAUN | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Nov 5, 2014 | GAUD | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Nov 5, 2014 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Sep 16, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 9, 2014 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 9, 2014 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 9, 2014 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 12, 2014 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 6, 2013 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 5, 2013 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 5, 2013 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 5, 2013 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 17, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2013 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 1, 2013 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 1, 2013 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 1, 2013 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 1, 2013 | ALIE | ASSIGNED TO LIE | — |
| Nov 1, 2012 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 1, 2012 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 1, 2012 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 11, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 11, 2012 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 10, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| May 24, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 24, 2011 | NWAP | NEW APPLICATION ENTERED | — |